Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01161589 · ClinicalTrials.gov registry record
First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data
A clinical trial of Atrial Fibrillation and Ventricular Tachycardia, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 142
- Enrollment target
- 4
- Study locations
NCT01161589 is a study of Atrial Fibrillation and Ventricular Tachycardia that has completed, run by Boston Scientific Corporation. The registered enrollment target is 142 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT01161589, a study of Atrial Fibrillation and Ventricular Tachycardia, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 142 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this clinical study is to collect simultaneous, multiple view cardiac signals representing both transvenous ICDs (T-ICD) and sensing vectors from the subcutaneous implantable defibrillator system (S-ICD). Upon completion, this data will represent the first true database capable of comparing detection characteristics of transvenous and subcutaneous ICDs. Future protocols will be created to dictate the specific methods of such comparisons.
Conditions Studied
Study Locations (4)
Illinois
- University of Chicago - Chicago
South Carolina
- Medical University of South Carolina - Charleston
Virginia
- Virginia Commonwealth University - Richmond
Other
- Erasmus Medical Centre - Rotterdam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01161589
The ClinicalTrials.gov registry entry for NCT01161589 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT01161589 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Illinois, South Carolina, Virginia.
Frequently Asked Questions
What is clinical trial NCT01161589 about?
NCT01161589 is a clinical study titled "First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data". The purpose of this clinical study is to collect simultaneous, multiple view cardiac signals representing both transvenous ICDs (T-ICD) and sensing vectors from the subcutaneous implantable defibrillator system (S-ICD). Upon completion, this data will represent the first true database capable of com...
What is the current status of trial NCT01161589?
This trial is currently completed. The enrollment target is 142 participants. The study started on 2005-10. Estimated completion is 2008-11.
What conditions does trial NCT01161589 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Ventricular Tachycardia, Ventricular Fibrillation.
Who is sponsoring clinical trial NCT01161589?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01161589 being conducted?
This trial has 4 study locations across Illinois, South Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.